as of 12-26-2025 2:10pm EST
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 80.8M | IPO Year: | 2017 |
| Target Price: | N/A | AVG Volume (30 days): | 313.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.27 - $3.25 | Next Earning Date: | 12-15-2025 |
| Revenue: | $19,019,110 | Revenue Growth: | 49.46% |
| Revenue Growth (this year): | -29.33% | Revenue Growth (next year): | 51.71% |
See how HYFT stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "HYFT MindWalk Holdings Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.